SYNELISA CARDIOLIPIN ANTIBODIES— 510(k) K924421
Substantially EquivalentElias U.S.A., Inc.
FDA 510(k) clearance K924421 for SYNELISA CARDIOLIPIN ANTIBODIES, Substantially Equivalent on 1992-11-30. Applicant: Elias U.S.A., Inc.. Device class: 2.
Clearance details
- Applicant
- Elias U.S.A., Inc.
- Product code
- Code MID
- Device class
- Class 2
- Regulation
- 21 CFR 866.5660
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Osceola, WI, US
Recent devices under product code MID
view allMore clearances from Elias U.S.A., Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.